KCNQ1 rs8234: Understanding Genetic Modifiers in Heart Health
The rs8234 variant is a single nucleotide polymorphism located in the 3' untranslated region (3'UTR) of the KCNQ1 gene. Research suggests this variant may act as a genetic modifier, influencing the severity of symptoms and the duration of the heart rate-corrected QT interval (QTc) in individuals with type 1 long QT syndrome.
What each genotype means
Potential QTc modifier
This genotype is a common variant in the 3'UTR of the KCNQ1 gene. Research suggests that when this variant is present on the same chromosome as a disease-causing KCNQ1 mutation, it may influence the severity of QTc interval prolongation and associated symptoms, though findings have been inconsistent across different populations. Please discuss any concerns regarding your heart rhythm or medication management with your clinician or pharmacist.
This genotype is common, with the minor allele frequency for this variant reported at approximately 38.5% in large population databases like gnomAD.
Potential QTc modifier
This genotype is a common variant in the 3'UTR of the KCNQ1 gene. Research suggests that when this variant is present on the same chromosome as a disease-causing KCNQ1 mutation, it may influence the severity of QTc interval prolongation and associated symptoms, though findings have been inconsistent across different populations. Please discuss any concerns regarding your heart rhythm or medication management with your clinician or pharmacist.
This genotype is common, with the minor allele frequency for this variant reported at approximately 38.5% in large population databases like gnomAD.
Potential QTc modifier
This genotype is a common variant in the 3'UTR of the KCNQ1 gene. Research suggests that when this variant is present on the same chromosome as a disease-causing KCNQ1 mutation, it may influence the severity of QTc interval prolongation and associated symptoms, though findings have been inconsistent across different populations. Please discuss any concerns regarding your heart rhythm or medication management with your clinician or pharmacist.
This genotype is common, with the minor allele frequency for this variant reported at approximately 38.5% in large population databases like gnomAD.
What is the rs8234 Variant?
The rs8234 variant is a specific change in the DNA sequence located within the 3' untranslated region (3'UTR) of the KCNQ1 gene. Unlike variants that change the protein structure itself, 3'UTR variants are often involved in regulating how much protein is produced from a gene. By sitting in this regulatory region, rs8234 is thought to influence the stability or expression levels of KCNQ1 messenger RNA. This gene is responsible for encoding the Kv7.1 potassium channel, which is essential for the normal electrical activity of the heart. Because this variant sits in a regulatory area, scientists have investigated whether it can alter the balance of healthy and potentially dysfunctional potassium channels in the heart, particularly in individuals who already carry a disease-causing mutation in the same gene.
The Role of KCNQ1 in Heart Rhythm
KCNQ1 provides the instructions for creating the Kv7.1 potassium channel. These channels are critical for the repolarization phase of the cardiac action potential, which is the process that allows heart muscle cells to reset their electrical charge after each beat. When KCNQ1 function is impaired, the heart's electrical recovery is delayed, which can be measured on an electrocardiogram (ECG) as a prolonged QTc interval. This condition is known as long QT syndrome type 1 (LQT1). Because the heart takes longer to reset, it can become susceptible to irregular heart rhythms, or arrhythmias. Understanding how genetic variants like rs8234 influence this process is a major area of study, as it may help explain why some people with the same primary genetic mutation experience very different clinical outcomes.
Research and Evidence Strength
The evidence linking rs8234 to clinical outcomes is considered moderate and context-dependent. Early studies suggested that the derived allele of rs8234, when located on the same chromosome as a disease-causing KCNQ1 mutation, might be associated with a shorter QTc interval and fewer cardiac symptoms. However, subsequent research has shown that these effects are not always consistent across different populations or study cohorts. Some large-scale analyses have found that when controlling for specific, population-based mutations, the modifying effect of rs8234 becomes less clear or disappears entirely. This indicates that while rs8234 may play a role in some families or specific genetic backgrounds, it is not a universal predictor of disease severity. The scientific community continues to debate the extent to which these 3'UTR variants act as independent modifiers versus markers of other underlying genetic factors.
What You Can and Cannot Do With This Information
It is important to understand that genetic variants like rs8234 are complex and do not function in isolation. If you have received information about this variant, it is not a medical diagnosis and cannot predict your personal risk of heart disease or arrhythmia. Genetic modifiers are only one piece of a much larger puzzle that includes your overall genetic makeup, environment, and medical history. You should never use this information to make decisions about your health or medications. If you have concerns about your heart health, a family history of arrhythmias, or questions about your genetic test results, please discuss them with a qualified cardiologist or a genetic counselor. They can provide context based on your specific clinical situation and help you understand what, if any, follow-up is appropriate for your care.
How common is this variant?
The frequency of the rs8234 variant is variable across different ancestral groups, with the derived allele being common in many populations, often reaching a minor allele frequency of approximately 38-40% in some datasets.
Frequently asked questions
Is rs8234 a cause of long QT syndrome?
No, rs8234 is not considered a primary cause of long QT syndrome. It is studied as a potential genetic modifier that might influence the severity of the condition in people who already have a primary disease-causing mutation.
Should I be worried if I have the rs8234 variant?
The presence of this variant is common in the general population and is not a diagnosis of heart disease. You should not be worried based on this result alone, as it is only one of millions of variations in your genome.
Can this variant change how my heart medication works?
There is no current clinical evidence that rs8234 dictates specific medication dosing. Always consult your doctor or pharmacist before making any changes to your prescribed heart medications.
Where can I find more information about my specific genetic results?
If you have specific questions about your genetic report, the best resource is a board-certified genetic counselor or your primary healthcare provider. They can interpret your results in the context of your personal and family medical history.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs8234?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in KCNQ1
A 3'UTR variant in KCNQ1 that influences QTc interval duration through allele-specific expression effects.
A 3'UTR variant in KCNQ1 that acts as a regulatory element affecting cardiac repolarization phenotypes.
A rare variant in the KCNQ1 gene associated with Long QT syndrome.
Pathogenic missense variant associated with Long QT syndrome type 1.
This variant is associated with Long QT syndrome 1, a condition affecting the heart's electrical activity.
Pathogenic variant associated with Long QT Syndrome type 1 (Romano-Ward syndrome).